期刊文献+

药物结合物理疗法在胸腔镜肺癌根治术后患者静脉血栓栓塞症预防中的应用效果 被引量:3

Effect of drug combined with physical therapy in the prevention of venous thromboembolism after thoracoscopic radical resection of lung cancer
下载PDF
导出
摘要 目的探讨药物结合物理疗法在胸腔镜肺癌根治术后患者静脉血栓栓塞症预防中的应用效果。方法选取2016年1月至2020年12月福建医科大学附属第二医院300例胸腔镜肺癌根治术后患者作为研究对象,根据随机数字表法分成联合组(n=150)和物理组(n=150)。物理组采用物理预防,联合组在物理组的基础上使用药物预防。比较两组患者治疗前后血液相关指标[血红蛋白(Hb)、D-二聚体、纤维蛋白原(FIB)]变化及静脉血栓栓塞症、出血发生率。结果两组患者的胸管引流量、胸管滞留时间比较,差异无统计学意义(P>0.05)。联合组的术后住院时间短于物理组,差异有统计学意义(P<0.05)。两组患者治疗后的Hb水平比较,差异无统计学意义(P>0.05)。联合组治疗后的D-二聚体、FIB水平低于物理组,差异有统计学意义(P<0.05)。联合组的静脉血栓栓塞症总发生率低于物理组,差异有统计学意义(P<0.05)。两组患者的出血发生率比较,差异无统计学意义(P>0.05)。结论采取药物预防结合物理预防可以降低胸腔镜肺癌根治术后患者的静脉血栓栓塞症发生率,并缩短术后住院时间,且不增加术后引流量,不延长胸管滞留时间,安全性好,可作为肺癌术后预防静脉血栓栓塞症的重要措施。 Objective To explore the effect of drug combined with physical therapy in the prevention of venous thromboembolism after thoracoscopic radical resection of lung cancer.Methods A total of 300 patients after thoracoscopic radical resection of lung cancer in the Second Affiliated Hospital of Fujian Medical University from January 2016 to December 2020 were selected as the research objects.According to the random number table method,they were divided into combined group(n=150)and physical group(n=150).The physical group used physical prevention,and the combined group used drug prevention on the basis of the physical group.The changes of blood related indexes(hemoglobin[Hb],D-dimer,fibrinogen[FIB])before and after treatment and the incidence of venous thromboembolism and bleeding were compared between the two groups.Results There were no significant differences between the two groups in chest tube drainage volume and chest tube retention time(P>0.05).The postoperative hospital stay in the combined group was shorter than that in the physical group,and the difference was statistically significant(P<0.05).There was no significant difference in Hb level between the two groups after treatment(P>0.05).The levels of D-dimer and FIB in the combined group were lower than the physical group,the differences were statistically significant(P<0.05).The total incidence of venous thromboembolism was lower than the physical group,and the difference was statistically significant(P<0.05).There was no significant difference in the incidence of bleeding between the two groups(P>0.05).Conclusion Drug combined with physical therapy can reduce the incidence of venous thromboembolism in patients with radical thoracoscopic pulmonary cancer and shorten the postoperative hospitalization time,do not increase postoperative flow and prolong the retention of thoracic tube,which can serve as an important measure to prevent pulmonary cancer.
作者 江文坛 吴佳云 吴敬阳 林贤宾 林良安 杨建胜 JIANG Wentan;WU Jiayun;WU Jingyang;LIN Xianbin;LIN Liang′an;YANG Jiansheng(Department of Thoracic and Cardiovascular Surgery,the Second Affiliated Hospital of Fujian Medical University,Fujian Province,Quanzhou362000,China)
出处 《中国当代医药》 CAS 2022年第17期100-103,共4页 China Modern Medicine
基金 福建省自然科学基金资助项目(2020J01207)。
关键词 胸腔镜肺癌根治术 静脉血栓栓塞症 静脉血栓栓塞症发生率 预防措施 Radical thoracoscopic lung cancer Venous thromboembolism Incidence of venous thromboembolism Preventive measures
  • 相关文献

参考文献19

二级参考文献130

  • 1李晓强,王深明.深静脉血栓形成的诊断和治疗指南(第2版)[J].中国医学前沿杂志(电子版),2013,5(3):53-57. 被引量:127
  • 2赵永强.我国静脉血栓栓塞症的研究现状[J].中华内科杂志,2005,44(2):83-84. 被引量:39
  • 3鞠卫萍,周建华,李振光,吴喜娟,周丽.高血压脑出血合并下肢深静脉血栓形成抗凝治疗的有效性及安全性[J].山东医药,2007,47(7):37-38. 被引量:17
  • 4Ram i-Porta R, Bolejack V , Crowley J , et al. The IASLC LungCancer Staging P roject: Proposals for the Revisions of the TDescriptors in the Forthcom ing Eighth Edition of the TN MClassification for Lung Cancer [J] . J Thorac Oncol, 2015, 10( 7 ) :990-1003.
  • 5Asam ura II, Chansky K, Crowley J , et al. The InternationalAssociation for the Study of Lung Cancer Lung Cancer StagingProject : Proposals for the Revision of the N Descriptors in theForthcom ing 8th Edition of the TN M Classification for LungCancer [J] . J Thorac Oncol 2015,10(12) : 1675-1684.
  • 6E berhardt W E, M itchell AM , Crowley J, et al. The IASLCLung Cancer Staging P roject: Proposals for the Revisions of theM Descriptors in the Forthcom ing Eighth Edition of the TN MClassification for Lung Cancer [J] . J Thorac Oncol, 2015, 10(11) :1515-1522.
  • 7International Association for the Study of Lung Cancer. StagingM anual in Thoracic Oncology [M] . 2009.
  • 8Ram i-Porta R, Goldstraw P. Strength and weakness of the newT N M classification for lung cancer [J] . Eur Respir J, 2010,36( 2 ) :237-239.
  • 9Ram i-Porta R, Bolejack V , Giroux D J, et al. The IASLC lungcancer staging project: the new database to inform the eighthedition of the TN M classification of lung cancer [J] . J ThoracOncol, 2 0 1 4 ,9 (1 1 ):1618-1624.
  • 10De Ruysscher D, W anders R, van Baardwijk A , et al. Radicaltreatm ent of non-small-cell lung cancer patients w ithsynchronous oligom etastases: long-term results of a prospectivephase 11 trial (N ct01282450) [J] . J Thorac Oncol, 2 0 1 2,7(10):1547-1555.

共引文献316

同被引文献30

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部